CoreValve bioprosthesis dysfunction treated with a Sapien 3 valve-in-valve transcatheter aortic valve replacement and BASILICA technique

Ravi K Sharma; Mark K Tuttle; Marie-France Poulin; Roger J Laham

doi:10.1002/ccd.29544

CoreValve bioprosthesis dysfunction treated with a Sapien 3 valve-in-valve transcatheter aortic valve replacement and BASILICA technique

Catheter Cardiovasc Interv. 2021 Aug 1;98(2):403-406. doi: 10.1002/ccd.29544. Epub 2021 Feb 17.

Authors

Ravi K Sharma^{1

2}, Mark K Tuttle¹, Marie-France Poulin¹, Roger J Laham¹

Affiliations

¹ Cardiovascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
² Norton Heart and Vascular Institute, Louisville, Kentucky, USA.

PMID: 33595150
DOI: 10.1002/ccd.29544

Abstract

Structural deterioration of transcatheter heart valve (THV) has been previously described. With the expansion of transcatheter aortic valve replacement (TAVR) indications toward treating lower risk patients with longer life expectancy, there will be increased necessity of managing the patients with THV dysfunction including those at risk for coronary obstruction or sinus sequestration. Coronary access also remains a challenge in such cases with THV dysfunction undergoing valve-in-transcatheter heart valve (ViTHV) TAVR. A unique and first reported case of THV deterioration treated with Sapien 3 ViTHV-TAVR inside a 31 mm CoreValve bioprosthesis along with left coronary leaflet laceration using the BASILICA technique has been presented.

Keywords: BASILICA technique; transcatheter heart valve dysfunction; valve in valve TAVR.

Publication types

Case Reports

MeSH terms

Aortic Valve / diagnostic imaging
Aortic Valve / surgery
Aortic Valve Stenosis* / diagnostic imaging
Aortic Valve Stenosis* / surgery
Bioprosthesis*
Heart Valve Prosthesis*
Humans
Prosthesis Design
Transcatheter Aortic Valve Replacement* / adverse effects
Treatment Outcome